Logo
Banner

Lalistat 1

Cat No.:
LIA017
Price:
Chemical Structure:

Description of Lalistat 1

Lalistat 1 is a potent, selective, and competitive inhibitor of lysosomal acid lipase (LAL) and against purified human LAL (phLAL) with an IC50 of 68 nM. Lalistat 1 is a inhibitor of immunoglobulin A1 protease (IgA1P) proteases for H. influenzae, has less effects on other serine hydrolases (trypsin or β-lactamase, etc.).

Product Information of Lalistat 1

Purity
0.9871
Molecular Weight
298.36
Formula
C12H18N4O3S
CAS Number
501104-16-1
Pack Size
5 mg/10 mg/50 mg
IC50
68 nM
Target
Human LAL
Applications
Lalistat 1 can be used for the research of niemann-pick type C (NPC) disease.
Storage
Store at -20°C, sealed storage, away from moisture.
Shipping Conditions
Room temperature in continental US, may vary elsewhere.
In Vitro Studies
Lalistat 1 (0-100 μM) shows activity against different non-typeable H. influenzae (NTHi) IgAP variants from clinical isolates in Elisa assay. It shows a dose-dependent inhibition of IgA1P B1 and B2, but at higher inhibitor concentrations, consistent with the higher expression levels of these variants. Nearly complete inhibition of IgA1P B1 and B2 is observed at 50 μM, with complete inhibition at 100 μM.

For research use only, not intended for any clinical use.